Parasitic helminths : targets, screens, drugs and vaccines /

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Caffrey, Conor R.
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Weinheim, Germany : Wiley-VCH, 2012.
Σειρά:Drug discovery in infectious diseases ; v. 3.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Part one: targets
  • Ligand-gated ion channels as targets for anthelmintic drugs: past, current, and future perspectives
  • How relevant is Caenorhabditis elegans as a model for the analysis of parasitic nematode biology?
  • Integrating and mining helminth genomes to discover and prioritize novel therapeutic targets
  • Recent progress in transcriptomics of key gastrointestinal nematodes of animals: fundamental research toward new intervention strategies
  • Harnessing genomic technologies to explore the molecular biology of liver flukes-major implications for fundamental and applied research
  • RNA interference: a potential discovery tool for therapeutic targets of parasitic nematodes
  • RNA interference as a tool for drug discovery in parasitic flatworms
  • Part two: screens
  • Mechanism-based screening strategies for anthelmintic discovery
  • Identification and profiling of nematicidal compounds in veterinary parasitology
  • Quantitative high-content screening-based drug discovery against helmintic diseases
  • Use of rodent models in the discovery of novel anthelmintics
  • To kill a mocking worm: strategies to improve Caenorhabditis elegans as a model system for use in anthelmintic discovery
  • Part three: drugs
  • Anthelmintic drugs: tools and shortcuts for the long road from discovery to product
  • Antinematodal drugs: modes of action and resistance: and worms will not come to thee (Shakespeare: Cymbeline: iv, ii)
  • Drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes
  • Promise of Bacillus thuringiensis crystal proteins as anthelmintics
  • Monepantel: from discovery to mode of action
  • Discovery, mode of action, and commercialization of derquantel
  • Praziquantel: too good to be replaced?
  • Drug discovery for trematodiases: challenges and progress
  • Part four: vaccines
  • Barefoot thru' the valley of darkness: preclinical development of a human hookworm vaccine
  • Vaccines linked to chemotherapy: a new approach to control helminth infections
  • Antifilarial vaccine development: present and future approaches
  • Proteases as vaccines against gastrointestinal nematode parasites of sheep and cattle
  • Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates
  • Sm14 Schistosoma mansoni fatty acid-binding protein: molecular basis for an antihelminth vaccine
  • Mechanisms of immune modulation by Fasciola hepatica: importance for vaccine development and for novel immunotherapeutics
  • Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke)
  • Vaccines against cestode parasites.